predictors of remission from life-time nicotine, alcohol, cannabis or cocaine dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions”, Addiction, 106(3), pp. 657-69. 3. Degenhardt, L., Cheng, H. y Anthony, J. C. (2007) “Assessing cannabis dependence in community surveys: methodological issues”, International journal of methods in psychiatric research, 16(2), pp. 43–51. 4. Fergusson, D. M., Horwood, L. J., Lynskey, M. T. y Madden, P. A. (2003) “Early reactions to cannabis predict later dependence” Arch Gen Psychiatry, 60, pp. 1.033-1.039. 5. Poulton, R.G., Brooke, M., Moffitt, T. E., et al. (2019) “Prevalence and correlates of cannabis use and dependence in young New Zealanders”, N Z Med J, 110, pp. 68-70. 6. Nielsen, S., Gowing, L., Sabioni, P. y Le Foll, B. (2019) “Pharmacotherapies for cannabis dependence”, Cochrane Database of Systematic Reviews. 7. Allsop, D. J., Copeland, J., Lintzeris, N., Dunlop, A. J., Montebello, M., Sadler, C., Rivas, G. R., Holland, R. M., Muhleisen, P., Norberg, M. M., Booth, J. y McGregor, I. S. (2014) “Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial”, JAMA Psychiatry, 71(3), pp. 281–291. 8. Lintzeris, N., Bhardwaj, A., Mills, L., et al. (2019) “Nabiximols for the Treatment of Cannabis Dependence: A Randomized Clinical Trial”, JAMA Intern Med., 179(9), pp. 1.242-1.253. 9. Lintzeris, N., Mills, L., Dunlop, A., Copeland, J., Mcgregor, I., Bruno, R., Kirby, A., Montebello, M., Hall, M., Jefferies, M., Kevin, R., Bhardwaj, A. yAgonist Replacement For Cannabis Dependence Study Group (Arc-D) (2020) “Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial”, Drug and alcohol dependence, 215. 10. Trigo, J. M., Lagzdins, D., Rehm, J., Selby, P., Gamaleddin, I., Fischer, B., Barnes, A. J., Huestis, M. A. y Le Foll, B. (2016) “Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings”, Drug and alcohol dependence, 161, pp. 298–306 11. Trigo, J. M., Soliman, A., Staios, G., Quilty, L., Fischer, B., George, T. P., Rehm, J., Selby, P., Barnes, A. J., Huestis, M. A. y Le Foll, B. (2016) “Sativex Associated With Behavioral-Relapse Prevention Strategy as Treatment for Cannabis Dependence: A Case Series”, Journal of addiction medicine, 10(4), pp. 274–279.
RkJQdWJsaXNoZXIy NTU4MzA1